Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
Brief Summary: The purpose of this study was to evaluated the effectiveness of inactivated poliovirus vaccine at a vaccine schedule that is commonly used in developing countries. The effectiveness of inactivated poliovaccine given at this schedule is important to national policy makers as they consider vaccination policies after the use of oral polio vaccine is discontinued.


Options:
A: Arm Label: G1: Sanofi bOPV Control; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2) | Arm Label: G2: Sanofi bOPV Control; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2) | Arm Label: G3: Trivalent OPV Control; Type: EXPERIMENTAL; Interventions: Biological: Trivalent Oral Polio Vaccine (tOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2) | Arm Label: G4: Sanofi bOPV, Sanofi IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Sanofi-Pasteur IPV (Sanofi IPV) | Arm Label: G5: Sanofi bOPV, Sanofi 2 IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Sanofi-Pasteur IPV (Sanofi IPV) | Arm Label: G6: Sanofi bOPV, GSK IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Glaxo SmithKline IPV (GSK IPV) | Arm Label: G7: Sanofi bOPV, GSK 2 IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Glaxo SmithKline IPV (GSK IPV) | Arm Label: G8: Sanofi bOPV, SII IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Serum Institute of India IPV (SII IPV) | Arm Label: G9: Sanofi bOPV, SII 2 IPV; Type: EXPERIMENTAL; Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV), Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2), Biological: Serum Institute of India IPV (SII IPV) | Intervention Type: BIOLOGICAL; Name: Bivalent Oral Polio Vaccine (bOPV); Assigned to Arm(s): G1: Sanofi bOPV Control, G2: Sanofi bOPV Control, G4: Sanofi bOPV, Sanofi IPV, G5: Sanofi bOPV, Sanofi 2 IPV, G6: Sanofi bOPV, GSK IPV, G7: Sanofi bOPV, GSK 2 IPV, G8: Sanofi bOPV, SII IPV, G9: Sanofi bOPV, SII 2 IPV | Intervention Type: BIOLOGICAL; Name: Trivalent Oral Polio Vaccine (tOPV); Assigned to Arm(s): G3: Trivalent OPV Control | Intervention Type: BIOLOGICAL; Name: Monovalent Oral Polio Vaccine Type 2 (mOPV2); Assigned to Arm(s): G1: Sanofi bOPV Control, G2: Sanofi bOPV Control, G3: Trivalent OPV Control, G4: Sanofi bOPV, Sanofi IPV, G5: Sanofi bOPV, Sanofi 2 IPV, G6: Sanofi bOPV, GSK IPV, G7: Sanofi bOPV, GSK 2 IPV, G8: Sanofi bOPV, SII IPV, G9: Sanofi bOPV, SII 2 IPV | Intervention Type: BIOLOGICAL; Name: Sanofi-Pasteur IPV (Sanofi IPV); Assigned to Arm(s): G4: Sanofi bOPV, Sanofi IPV, G5: Sanofi bOPV, Sanofi 2 IPV | Intervention Type: BIOLOGICAL; Name: Glaxo SmithKline IPV (GSK IPV); Assigned to Arm(s): G6: Sanofi bOPV, GSK IPV, G7: Sanofi bOPV, GSK 2 IPV | Intervention Type: BIOLOGICAL; Name: Serum Institute of India IPV (SII IPV); Assigned to Arm(s): G8: Sanofi bOPV, SII IPV, G9: Sanofi bOPV, SII 2 IPV
B: Intervention Type: BIOLOGICAL; Name: Inactivated Polio Vaccine given at an accelerated schedule; Assigned to Arm(s): N/A
C: Arm Label: IPV/IPV/IPV/Rotarix/mOPV type 2; Type: EXPERIMENTAL; Interventions: Biological: IPV, Biological: mOPV type 2, Biological: Rotarix | Arm Label: IPV/IPV/bOPV/Rotarix/mOPV type 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: IPV, Biological: bOPV, Biological: mOPV type 2, Biological: Rotarix | Arm Label: IPV/bOPV/bOPV/Rotarix/mOPV type 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: IPV, Biological: bOPV, Biological: mOPV type 2, Biological: Rotarix | Intervention Type: BIOLOGICAL; Name: IPV; Assigned to Arm(s): IPV/IPV/IPV/Rotarix/mOPV type 2, IPV/IPV/bOPV/Rotarix/mOPV type 2, IPV/bOPV/bOPV/Rotarix/mOPV type 2 | Intervention Type: BIOLOGICAL; Name: bOPV; Assigned to Arm(s): IPV/IPV/bOPV/Rotarix/mOPV type 2, IPV/bOPV/bOPV/Rotarix/mOPV type 2 | Intervention Type: BIOLOGICAL; Name: mOPV type 2; Assigned to Arm(s): IPV/IPV/IPV/Rotarix/mOPV type 2, IPV/IPV/bOPV/Rotarix/mOPV type 2, IPV/bOPV/bOPV/Rotarix/mOPV type 2 | Intervention Type: BIOLOGICAL; Name: Rotarix; Assigned to Arm(s): IPV/IPV/IPV/Rotarix/mOPV type 2, IPV/IPV/bOPV/Rotarix/mOPV type 2, IPV/bOPV/bOPV/Rotarix/mOPV type 2
D: Arm Label: IPV Group; Type: EXPERIMENTAL; Interventions: Biological: Poliorix | Intervention Type: BIOLOGICAL; Name: Poliorix; Assigned to Arm(s): IPV Group

Answer: B